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One of the goals from Sustainable Development Goals (SDGs) by WHO is to decrease maternal and neonatal
morbidity.1 A significant part of these morbidities are attributed by Human Immunodeficiency Virus (HIV)
infection in the pregnant women.1 Our effort in controlling maternal to child transmission of HIV infection has
been relatively effective with a significant decrease of transmission from 12 % in 1999 to approximately 2%
in 2007.2 The success has been mostly due to the use of highly effective anti-retroviral (ARV) therapy, primary
pre-labor cesarean section, prophylaxis ARV for neonate, and avoidance of breastfeeding.1-3
Recent studies in the field has also improved our management to prevent maternal to child HIV transmission
such as, better safety profile of ARVs that are now encouraged to be given in "ALL" HIV infected pregnancies
as early as possible, even in the first trimester.3,4 Improvement can also be seen in the management of specific
resource settings, such as planned vaginal delivery in patients with undetectable viral load;5 as well as, selective
breastfeeding in these patients.5
Despite significant advances in prevention maternal to child HIV transmission, the problem remains elusive
to eradicate. Screening of HIV infection in high risk population by voluntary counseling and testing (VCT) has
helped a little difference. As recent studies showed that most HIV infections are found not only in high risk
populations, but also in low risk individuals (ex. house wives) with high risk partners.6
How can we eradicate HIV transmission to the next generation? The best answer is whether we cannot find
these infections anymore. The need for us to eradicate or to bring nil vertical transmission proposes a more
effective approach in HIV screening on pregnant women. Universal screening may help in early detection and
prompt ARV treatment of HIV infected pregnant women.7 The Jakarta municipal government health services
have proven that universal screening of HIV in pregnant women is feasible.8 If we are truly committed to
eradicate maternal to child HIV transmission, we may have to consider engagement of a nationwide program
for a universal screening system of HIV in all pregnant women. At least in practice, we offer 80% of all pregnant
women to be checked.
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